Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): A pragmatic, open-label, randomised controlled trial

The Lancet Jan 12, 2019

Naslund U, et al. - A total of 3,532 subjects recruited between April 29, 2013 and June 7, 2016 were assessed to examine the role of ultrasound-based pictorial information regarding subclinical carotid atherosclerosis (targeting both primary care physicians and patients) for prevention of cardiovascular disease in a randomized controlled trial. Individuals aged 40, 50, or 60 years with one or more conventional risk factors were eligible. Researchers observed a decline in Framingham risk score (FRS) from baseline to 1-year follow-up in the intervention group and an increase in the control group. They determined a contributory role of pictorial presentation of silent atherosclerosis for the prevention of cardiovascular disease. They also suggested medication and lifestyle modifications to reduce the prevalence of cardiovascular disease.

Go to Original
Non loggedin lock

To read this article Sign up / Login for free

This article is only available to members. Are you a doctor? Click here to signup for free.
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen